U.S., May 17 -- ClinicalTrials.gov registry received information related to the study (NCT06975891) titled 'Performance of Systane PRO Versus Refresh Optive Mega-3' on May 08.
Brief Summary: Single site, prospective, double-masked, randomized-controlled, cross-over study of the subjective and objective performance of 2 different eyedrops. Subjects will be assessed at a screening visit, and 3 follow-up visits. Clinical evaluations will include patient questionnaires.
Study Start Date: June 01
Study Type: INTERVENTIONAL
Condition:
Dry Eye
Intervention:
DRUG: Systane PRO
Lubricating Eyedrops
DRUG: Refresh Optive MEGA-3
Lubricating Eyedrops
Recruitment Status: RECRUITING
Sponsor: Scripps Poway Eyecare and Optometry
Published by HT ...